Hanmi CEO Sae-Chang Kwon, “We applied FDA approval for Rolontis and Olita’s Phase III clinical trial”

Published: 2018-02-13 16:29:00
Updated: 2018-02-13 16:21:41

Hanmi Pharm(CEO Sae-Chang Kwon) has set the ‘Hanmi Innovative Management to Become Pharmaceutical Power’ ’as their new year’s resolution.

“During my more than 20-year career at Hanmi, I’ve always done a new thing every year, not the same work,” said CEO Sae-Chang Kwon, “As I take our R&D work as...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Most Read News

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.